Serum Institute CEO Adar Poonawalla takes Covishield jab to 'endorse its safety and efficacy'
Poonawalla's SII, the largest vaccine manufacturer globally, has provided 11 million Covishield doses to the Centre.
Full Article
Serum Institute CEO Adar Poonawalla takes Covishield jab to 'endorse its safety and efficacy'
DNA
0 shares
1 views
You might like
Related news coverage
Serum Institute of India plans to launch Covovax by June: Adar Poonawalla
IndiaTimes
SII CEO Adar Poonawalla said on Saturday that its partnership for a Covid-19 vaccine with Novavax has shown excellent efficacy..
-
Serum Institute applies to conduct local trial for Novavax vaccine: CEO
IndiaTimes
-
Serum Institute of India fire: Five charred bodies recovered from building, says Pune mayor; Covishield facility not affected
Zee News
-
SII CEO Adar Poonawalla gets Covishield jab, shares special message for PM Modi
Zee News
-
Coronavirus | Emotional moment for Serum Institute of India team, says Poonawalla
Hindu
Advertisement
More coverage
COVID-19: Serum Institute CEO Adar Poonawalla reveals cost of Covishield vaccine in private markets - Check price here
DNA
Serum Institute of India CEO Adar Poonawalla on Tuesday (January 12) said that 'Covishield' will be made available in private..
-
COVID-19 vaccine to cost Rs 219-292 to govt, Rs 438- 584 for pvt buyers: Serum Institute
Mid-Day
-
Yet to receive licence to export Covishield: SII
Mid-Day
-
COVID-19: Serum Institute CEO Adar Poonawalla reveals cost of Covishield vaccine - Check price here
Zee News
-
Ready to roll out COVID-19 vaccine in India: Serum
Mid-Day